Copenhagen, 2018-02-13 13:55 CET (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): The annual general meeting of
ALK-Abelló A/S will take place on Monday 12 March 2018 at 16:00 (CET) at
ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark. The agenda of the meeting
including the complete proposals from the Board of Directors to the AGM is
attached.
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 2014
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and
allergic asthma. It markets allergy immunotherapy treatments and other products
and services for people with allergy and allergy doctors. Headquartered in
Hørsholm, Denmark, ALK employs around 2,300 people worldwide and is listed on
Nasdaq Copenhagen. Find more information at www.alk.net.
Attachment:
https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=663352© 2018 GlobeNewswire
